Skip to main content
Top
Published in: Current Treatment Options in Neurology 4/2017

Open Access 01-04-2017 | Neurologic Manifestations of Systemic Disease (N Scolding and C Rice, Section Editors)

Neurological Manifestations of IgG4-Related Disease

Authors: Bernardo Baptista, MD, Alina Casian, MA MRCP, Harsha Gunawardena, MRCP(UK) PhD, David D’Cruz, MD FRCP, Claire M. Rice, MRCP(UK) PhD

Published in: Current Treatment Options in Neurology | Issue 4/2017

Login to get access

Opinion statement

IgG4-related disease (IgG4-RD) is a multisystem inflammatory disorder. Early recognition of IgG4-RD is important to avoid permanent organ dysfunction and disability. Neurological involvement by IgG4-RD is relatively uncommon, but well recognised—hypertrophic pachymeningitis and hypophysitis are the most frequent manifestations. Although the nervous system may be involved in isolation, this more frequently occurs in conjunction with involvement of other systems. Elevated circulating levels of IgG4 are suggestive of the condition, but these are not pathognomonic and exclusion of other inflammatory disorders including vasculitis is required. Wherever possible, a tissue diagnosis should be established. The characteristic histopathological changes include a lymphoplasmacytoid infiltrate, storiform fibrosis and obliterative phlebitis. IgG4-RD typically responds well to treatment with glucocorticoids, although relapse is relatively common and treatment with a steroid-sparing agent or rituximab may be required. Improved understanding of the pathogenesis of IgG4-RD is likely to lead to the development of more specific disease treatments in the future.
Literature
2.
go back to reference •• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–51. doi:10.1056/NEJMra1104650. Succinct review of the clinical, pathological and radiological manifestations of IgG4-related disease.PubMedCrossRef •• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–51. doi:10.​1056/​NEJMra1104650. Succinct review of the clinical, pathological and radiological manifestations of IgG4-related disease.PubMedCrossRef
3.
go back to reference Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061–7. doi:10.1002/art.34593.PubMedCrossRef Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061–7. doi:10.​1002/​art.​34593.PubMedCrossRef
5.
go back to reference • Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92. doi:10.1038/modpathol.2012.72. Consensus statement of international experts regarding the diagnosis of IgG4-related disease based primarily on histopathological appearances.PubMedCrossRef • Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92. doi:10.​1038/​modpathol.​2012.​72. Consensus statement of international experts regarding the diagnosis of IgG4-related disease based primarily on histopathological appearances.PubMedCrossRef
9.
go back to reference • Brito-Zeron P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine (Baltimore). 2016;95(26):e4002. doi:10.1097/MD.0000000000004002. Systematic review of therapeutic strategies in IgG4-related disease.CrossRef • Brito-Zeron P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine (Baltimore). 2016;95(26):e4002. doi:10.​1097/​MD.​0000000000004002​. Systematic review of therapeutic strategies in IgG4-related disease.CrossRef
10.
go back to reference •• Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688–99. doi:10.1002/art.39132. Expert guidance statements on the management of IgG4-related disease which also highlights areas where the degree of consensus amongst experts was low.PubMedCrossRef •• Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688–99. doi:10.​1002/​art.​39132. Expert guidance statements on the management of IgG4-related disease which also highlights areas where the degree of consensus amongst experts was low.PubMedCrossRef
13.
go back to reference Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A case of Mikulicz’s disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand J Rheumatol. 2006;35(5):410–1. doi:10.1080/03009740600758110.PubMedCrossRef Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A case of Mikulicz’s disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand J Rheumatol. 2006;35(5):410–1. doi:10.​1080/​0300974060075811​0.PubMedCrossRef
15.
16.
go back to reference Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688–98.PubMedCrossRef Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688–98.PubMedCrossRef
17.
go back to reference Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.PubMedCrossRef Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.PubMedCrossRef
18.
go back to reference Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjogren’s syndrome: a syndrome complex. Am J Surg. 1984;147(6):822–6.PubMedCrossRef Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjogren’s syndrome: a syndrome complex. Am J Surg. 1984;147(6):822–6.PubMedCrossRef
19.
go back to reference Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359(9315):1403–4.PubMedCrossRef Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359(9315):1403–4.PubMedCrossRef
20.
go back to reference Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52(5):683–7.PubMedPubMedCentralCrossRef Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52(5):683–7.PubMedPubMedCentralCrossRef
23.
go back to reference Saeki T, Saito A, Hiura T, Yamazaki H, Emura I, Ueno M, et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med. 2006;45(3):163–7.PubMedCrossRef Saeki T, Saito A, Hiura T, Yamazaki H, Emura I, Ueno M, et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med. 2006;45(3):163–7.PubMedCrossRef
25.
go back to reference Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology. 2006;6(1–2):132–7. doi:10.1159/000090033.PubMedCrossRef Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology. 2006;6(1–2):132–7. doi:10.​1159/​000090033.PubMedCrossRef
27.
32.
go back to reference Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford). 2015;54(11):1982–90. doi:10.1093/rheumatology/kev203.CrossRef Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford). 2015;54(11):1982–90. doi:10.​1093/​rheumatology/​kev203.CrossRef
34.
go back to reference •• Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680. doi:10.1097/MD.0000000000000680. Relatively large retrospective review of patients with IgG4-related disease reporting extent of multi-organ involvement.CrossRef •• Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680. doi:10.​1097/​MD.​0000000000000680​. Relatively large retrospective review of patients with IgG4-related disease reporting extent of multi-organ involvement.CrossRef
35.
37.
41.
go back to reference Stone JH. IgG4-related disease: pathophysiologic insights drive emerging treatment approaches. Clin Exp Rheumatol. 2016;34(4 Suppl 98):66–8.PubMed Stone JH. IgG4-related disease: pathophysiologic insights drive emerging treatment approaches. Clin Exp Rheumatol. 2016;34(4 Suppl 98):66–8.PubMed
46.
go back to reference Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Baas F, Elferink RP, et al. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology. 2013;57(6):2390–8. doi:10.1002/hep.26232.PubMedCrossRef Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Baas F, Elferink RP, et al. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology. 2013;57(6):2390–8. doi:10.​1002/​hep.​26232.PubMedCrossRef
48.
go back to reference Della-Torre E, Passerini G, Furlan R, Roveri L, Chieffo R, Anzalone N, et al. Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis. J Rheumatol. 2013;40(11):1927–9. doi:10.3899/jrheum.130678.PubMedCrossRef Della-Torre E, Passerini G, Furlan R, Roveri L, Chieffo R, Anzalone N, et al. Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis. J Rheumatol. 2013;40(11):1927–9. doi:10.​3899/​jrheum.​130678.PubMedCrossRef
50.
go back to reference Mattoo H, Della-Torre E, Mahajan VS, Stone JH, Pillai S. Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy. Allergy. 2014;69(3):399–402. doi:10.1111/all.12342.PubMedCrossRef Mattoo H, Della-Torre E, Mahajan VS, Stone JH, Pillai S. Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy. Allergy. 2014;69(3):399–402. doi:10.​1111/​all.​12342.PubMedCrossRef
51.
go back to reference Mateos MV, Granell M, Oriol A, Martinez-Lopez J, Blade J, Hernandez MT, et al. Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma. Br J Haematol. 2016;175(3):448–56. doi:10.1111/bjh.14263.PubMedCrossRef Mateos MV, Granell M, Oriol A, Martinez-Lopez J, Blade J, Hernandez MT, et al. Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma. Br J Haematol. 2016;175(3):448–56. doi:10.​1111/​bjh.​14263.PubMedCrossRef
53.
go back to reference Riku S, Kato S. Idiopathic hypertrophic pachymeningitis. Neuropathol Off J Jpn Soc Neuropathol. 2003;23(4):335–44.CrossRef Riku S, Kato S. Idiopathic hypertrophic pachymeningitis. Neuropathol Off J Jpn Soc Neuropathol. 2003;23(4):335–44.CrossRef
54.
go back to reference De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, et al. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res. 2016;1–9. doi:10.1007/s12026-016-8863-1. De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, et al. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res. 2016;1–9. doi:10.​1007/​s12026-016-8863-1.
59.
67.
go back to reference Tajima Y, Mito Y. Cranial neuropathy because of IgG4-related pachymeningitis; intracranial and spinal mass lesions. BMJ Case Rep. 2012. doi:10.1136/bcr2012006471. Tajima Y, Mito Y. Cranial neuropathy because of IgG4-related pachymeningitis; intracranial and spinal mass lesions. BMJ Case Rep. 2012. doi:10.​1136/​bcr2012006471.
68.
go back to reference Yamashita H, Takahashi Y, Ishiura H, Kano T, Kaneko H, Mimori A. Hypertrophic pachymeningitis and tracheobronchial stenosis in IgG4-related disease: case presentation and literature review. Intern Med. 2012;51(8):935–41.PubMedCrossRef Yamashita H, Takahashi Y, Ishiura H, Kano T, Kaneko H, Mimori A. Hypertrophic pachymeningitis and tracheobronchial stenosis in IgG4-related disease: case presentation and literature review. Intern Med. 2012;51(8):935–41.PubMedCrossRef
74.
go back to reference Gu R, Hao PY, Liu JB, Wang ZH, Zhu QS. Cervicothoracic spinal cord compression caused by IgG4-related sclerosing pachymeningitis: a case report and literature review. Eur Spine J. 2016;25 Suppl 1:147–51. doi:10.1007/s00586-015-4251-0.PubMedCrossRef Gu R, Hao PY, Liu JB, Wang ZH, Zhu QS. Cervicothoracic spinal cord compression caused by IgG4-related sclerosing pachymeningitis: a case report and literature review. Eur Spine J. 2016;25 Suppl 1:147–51. doi:10.​1007/​s00586-015-4251-0.PubMedCrossRef
78.
go back to reference Bellastella G, Maiorino MI, Bizzarro A, Giugliano D, Esposito K, Bellastella A, et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary. 2016;19(6):625–42. doi:10.1007/s11102-016-0736-z.PubMedCrossRef Bellastella G, Maiorino MI, Bizzarro A, Giugliano D, Esposito K, Bellastella A, et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary. 2016;19(6):625–42. doi:10.​1007/​s11102-016-0736-z.PubMedCrossRef
80.
go back to reference Shimatsu A, Oki Y, Fujisawa I, Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J. 2009;56(9):1033–41.PubMedCrossRef Shimatsu A, Oki Y, Fujisawa I, Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J. 2009;56(9):1033–41.PubMedCrossRef
83.
go back to reference Iseda I, Hida K, Tone A, Tenta M, Shibata Y, Matsuo K, et al. Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis. Endocr J. 2014;61(2):195–203.PubMedCrossRef Iseda I, Hida K, Tone A, Tenta M, Shibata Y, Matsuo K, et al. Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis. Endocr J. 2014;61(2):195–203.PubMedCrossRef
84.
go back to reference Bando H, Iguchi G, Fukuoka H, Taniguchi M, Yamamoto M, Matsumoto R, et al. The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol. 2014;170(2):161–72. doi:10.1530/EJE-13-0642.PubMedCrossRef Bando H, Iguchi G, Fukuoka H, Taniguchi M, Yamamoto M, Matsumoto R, et al. The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol. 2014;170(2):161–72. doi:10.​1530/​EJE-13-0642.PubMedCrossRef
85.
go back to reference Bernreuther C, Illies C, Flitsch J, Buchfelder M, Buslei R, Glatzel M, et al. IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis. Brain Pathol. 2016. doi:10.1111/bpa.12459.PubMed Bernreuther C, Illies C, Flitsch J, Buchfelder M, Buslei R, Glatzel M, et al. IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis. Brain Pathol. 2016. doi:10.​1111/​bpa.​12459.PubMed
91.
go back to reference Kanagaraju V, Rai D, Alluri RV, Prasanna C, Shyam Sundar V, Arvind Kumar SM, et al. An inflammatory pseudotumor in the thoracic epidural space presenting with progressive paraplegia: a histopathological diagnosis with clinical and radiological uncertainty. Case report with literature review. Eur Spine J. 2016;25 Suppl 1:75–9. doi:10.1007/s00586-015-4106-8.PubMedCrossRef Kanagaraju V, Rai D, Alluri RV, Prasanna C, Shyam Sundar V, Arvind Kumar SM, et al. An inflammatory pseudotumor in the thoracic epidural space presenting with progressive paraplegia: a histopathological diagnosis with clinical and radiological uncertainty. Case report with literature review. Eur Spine J. 2016;25 Suppl 1:75–9. doi:10.​1007/​s00586-015-4106-8.PubMedCrossRef
93.
go back to reference Williams MM, Mashaly H, Puduvalli VK, Jin M, Mendel E. Immunoglobulin G4-related disease mimicking an epidural spinal cord tumor: case report. J Neurosurg Spine. 2017;26:76–80. doi:10.3171/2016.5.SPINE16119. Williams MM, Mashaly H, Puduvalli VK, Jin M, Mendel E. Immunoglobulin G4-related disease mimicking an epidural spinal cord tumor: case report. J Neurosurg Spine. 2017;26:76–80. doi:10.​3171/​2016.​5.​SPINE16119.
94.
go back to reference Okano A, Nakatomi H, Shibahara J, Tsuchiya T, Saito N. Intracranial inflammatory pseudotumors associated with immunoglobulin G4-related disease mimicking multiple meningiomas: a case report and review of the literature. World Neurosurg. 2015;83(6):1181.e1–4. doi:10.1016/j.wneu.2015.02.011.CrossRef Okano A, Nakatomi H, Shibahara J, Tsuchiya T, Saito N. Intracranial inflammatory pseudotumors associated with immunoglobulin G4-related disease mimicking multiple meningiomas: a case report and review of the literature. World Neurosurg. 2015;83(6):1181.e1–4. doi:10.​1016/​j.​wneu.​2015.​02.​011.CrossRef
97.
98.
99.
go back to reference Katsura M, Morita A, Horiuchi H, Ohtomo K, Machida T. IgG4-related inflammatory pseudotumor of the trigeminal nerve: another component of IgG4-related sclerosing disease? AJNR Am J Neuroradiol. 2011;32(8):E150–2. doi:10.3174/ajnr.A2256.PubMedCrossRef Katsura M, Morita A, Horiuchi H, Ohtomo K, Machida T. IgG4-related inflammatory pseudotumor of the trigeminal nerve: another component of IgG4-related sclerosing disease? AJNR Am J Neuroradiol. 2011;32(8):E150–2. doi:10.​3174/​ajnr.​A2256.PubMedCrossRef
104.
go back to reference Yamamoto M, Shimizu Y, Yajima H, Tabeya T, Suzuki C, Naishiro Y, et al. Validation of the comprehensive diagnostic criteria for IgG4-related disease in a SMART registry. Mod Rheumatol. 2016;26(2):310–2. doi:10.3109/14397595.2015.1069951.PubMed Yamamoto M, Shimizu Y, Yajima H, Tabeya T, Suzuki C, Naishiro Y, et al. Validation of the comprehensive diagnostic criteria for IgG4-related disease in a SMART registry. Mod Rheumatol. 2016;26(2):310–2. doi:10.​3109/​14397595.​2015.​1069951.PubMed
105.
go back to reference Della-Torre E, Lanzillotta M, Campochiaro C, Bozzalla E, Bozzolo E, Bandiera A, et al. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature. Medicine (Baltimore). 2016;95(34):e4633. doi:10.1097/MD.0000000000004633.CrossRef Della-Torre E, Lanzillotta M, Campochiaro C, Bozzalla E, Bozzolo E, Bandiera A, et al. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature. Medicine (Baltimore). 2016;95(34):e4633. doi:10.​1097/​MD.​0000000000004633​.CrossRef
106.
go back to reference Bando H, Iguchi G, Fukuoka H, Taniguchi M, Kawano S, Saitoh M, et al. A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis. Pituitary. 2015;18(5):722–30. doi:10.1007/s11102-015-0650-9.PubMedCrossRef Bando H, Iguchi G, Fukuoka H, Taniguchi M, Kawano S, Saitoh M, et al. A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis. Pituitary. 2015;18(5):722–30. doi:10.​1007/​s11102-015-0650-9.PubMedCrossRef
108.
go back to reference Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44(11):2432–7. doi:10.1016/j.humpath.2013.05.023.PubMedCrossRef Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44(11):2432–7. doi:10.​1016/​j.​humpath.​2013.​05.​023.PubMedCrossRef
109.
115.
117.
go back to reference Fujita A, Sakai O, Chapman MN, Sugimoto H. IgG4-related disease of the head and neck: CT and MR imaging manifestations. Radiographics: Rev Publ Radiol Soc North Am Inc. 2012;32(7):1945–58. doi:10.1148/rg.327125032.CrossRef Fujita A, Sakai O, Chapman MN, Sugimoto H. IgG4-related disease of the head and neck: CT and MR imaging manifestations. Radiographics: Rev Publ Radiol Soc North Am Inc. 2012;32(7):1945–58. doi:10.​1148/​rg.​327125032.CrossRef
118.
go back to reference Caputo C, Bazargan A, McKelvie PA, Sutherland T, Su CS, Inder WJ. Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy. Pituitary. 2014;17(3):251–6. doi:10.1007/s11102-013-0498-9.PubMedCrossRef Caputo C, Bazargan A, McKelvie PA, Sutherland T, Su CS, Inder WJ. Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy. Pituitary. 2014;17(3):251–6. doi:10.​1007/​s11102-013-0498-9.PubMedCrossRef
119.
go back to reference Haraguchi A, Era A, Yasui J, Ando T, Ueki I, Horie I, et al. Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J. 2010;57(8):719–25.PubMedCrossRef Haraguchi A, Era A, Yasui J, Ando T, Ueki I, Horie I, et al. Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J. 2010;57(8):719–25.PubMedCrossRef
120.
124.
go back to reference Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken). 2014;66(1):86–96. doi:10.1002/acr.22058.CrossRef Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken). 2014;66(1):86–96. doi:10.​1002/​acr.​22058.CrossRef
128.
go back to reference Tanabe T, Tsushima K, Yasuo M, Urushihata K, Hanaoka M, Koizumi T, et al. IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med. 2006;45(21):1243–7.PubMedCrossRef Tanabe T, Tsushima K, Yasuo M, Urushihata K, Hanaoka M, Koizumi T, et al. IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med. 2006;45(21):1243–7.PubMedCrossRef
131.
go back to reference Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas. 2005;31(1):28–31.PubMedCrossRef Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas. 2005;31(1):28–31.PubMedCrossRef
134.
go back to reference Culver EL, Sadler R, Simpson D, Cargill T, Makuch M, Bateman AC, et al. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort. Am J Gastroenterol. 2016;111(5):733–43. doi:10.1038/ajg.2016.40.PubMedCrossRef Culver EL, Sadler R, Simpson D, Cargill T, Makuch M, Bateman AC, et al. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort. Am J Gastroenterol. 2016;111(5):733–43. doi:10.​1038/​ajg.​2016.​40.PubMedCrossRef
135.
141.
142.
go back to reference Khosroshahi A, Cheryk LA, Carruthers MN, Edwards JA, Bloch DB, Stone JH. Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014;66(1):213–7. doi:10.1002/art.38193.PubMedCrossRef Khosroshahi A, Cheryk LA, Carruthers MN, Edwards JA, Bloch DB, Stone JH. Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014;66(1):213–7. doi:10.​1002/​art.​38193.PubMedCrossRef
146.
go back to reference Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop. 2011;51(1):13–20.PubMedCrossRef Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop. 2011;51(1):13–20.PubMedCrossRef
147.
go back to reference Masaki Y, Shimizu H, Sato Nakamura T, Nakamura T, Nakajima A, Iwao Kawanami H, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematop. 2014;54(2):95–101.PubMedCrossRef Masaki Y, Shimizu H, Sato Nakamura T, Nakamura T, Nakajima A, Iwao Kawanami H, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematop. 2014;54(2):95–101.PubMedCrossRef
149.
go back to reference Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012;91(1):57–66. doi:10.1097/MD.0b013e3182431ef6.CrossRef Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012;91(1):57–66. doi:10.​1097/​MD.​0b013e3182431ef6​.CrossRef
150.
go back to reference Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore). 2012;91(1):49–56. doi:10.1097/MD.0b013e3182433d77.CrossRef Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore). 2012;91(1):49–56. doi:10.​1097/​MD.​0b013e3182433d77​.CrossRef
151.
go back to reference Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7(10):1089–96. doi:10.1016/j.cgh.2009.03.021.PubMedCrossRef Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7(10):1089–96. doi:10.​1016/​j.​cgh.​2009.​03.​021.PubMedCrossRef
153.
go back to reference Kamisawa T, Okazaki K, Kawa S, Ito T, Inui K, Irie H, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013. III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49(6):961–70. doi:10.1007/s00535-014-0945-z.PubMedCrossRef Kamisawa T, Okazaki K, Kawa S, Ito T, Inui K, Irie H, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013. III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49(6):961–70. doi:10.​1007/​s00535-014-0945-z.PubMedCrossRef
155.
go back to reference Hori M, Makita N, Andoh T, Takiyama H, Yajima Y, Sakatani T, et al. Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J. 2010;57(6):485–92.PubMedCrossRef Hori M, Makita N, Andoh T, Takiyama H, Yajima Y, Sakatani T, et al. Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J. 2010;57(6):485–92.PubMedCrossRef
158.
go back to reference Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104(9):2295–306. doi:10.1038/ajg.2009.325.PubMedCrossRef Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104(9):2295–306. doi:10.​1038/​ajg.​2009.​325.PubMedCrossRef
160.
go back to reference Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607–15. doi:10.1136/gutjnl-2012-302886.PubMedCrossRef Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607–15. doi:10.​1136/​gutjnl-2012-302886.PubMedCrossRef
161.
164.
go back to reference Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62(6):1755–62. doi:10.1002/art.27435.PubMedCrossRef Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62(6):1755–62. doi:10.​1002/​art.​27435.PubMedCrossRef
165.
166.
Metadata
Title
Neurological Manifestations of IgG4-Related Disease
Authors
Bernardo Baptista, MD
Alina Casian, MA MRCP
Harsha Gunawardena, MRCP(UK) PhD
David D’Cruz, MD FRCP
Claire M. Rice, MRCP(UK) PhD
Publication date
01-04-2017
Publisher
Springer US
Published in
Current Treatment Options in Neurology / Issue 4/2017
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-017-0450-9